E Fund Management’s BeOne Medicines Ltd ONC Stock Holding History

E Fund Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-31,961	Closed	-$4.31M	–	360
2022 Q3	$4.31M	Sell	31,961 -258	-0.8%	-$44.3K	0.4%	34
2022 Q2	$5.21M	Buy	+32,219	New	+$5.03M	0.47%	33
2022 Q1	–	Sell	-11,572	Closed	-$3.13M	–	368
2021 Q4	$3.13M	Buy	+11,572	New	+$3.91M	0.11%	60

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

E Fund Management's ONC Position: Q4 2022 in Review

E Fund Management sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 31,961 shares — an estimated $4.31M sold.

E Fund Management first reported a position in ONC in Q4 2021 and held it in 3 quarters. The position peaked at $5.21M in Q2 2022. 213 funds tracked by Wall St. Rank hold ONC as of Q4 2022.

E Fund Management reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
E Fund Management sold 31,961 BeOne Medicines Ltd shares in Q4 2022, an estimated $4.31M.
E Fund Management first reported a position in BeOne Medicines Ltd in Q4 2021 and held it in 3 quarters.
E Fund Management's BeOne Medicines Ltd position peaked at $5.21M in Q2 2022.
213 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.

Based on E Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.